Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026 and Feb 2026.
- Largest single sale: $1.7M (122,349 shares) of Wave Life Sciences, Inc. on Dec 8, 2025. Filing
- Last sale before this period: Nov 8, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | SVP, Corporate Development, Head of Emerging Areas | Nov 10, 2015 | Feb 27, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 26, 2026, Wave Life Sciences, Inc.: sold 33,194 shares for $500K, under a disclosed plan; 33,194 shares acquired by exercising options. 1 filing: 1
- Feb 9, 2026, Wave Life Sciences, Inc.: sold 1,883 shares for $25K, to cover taxes. 1 filing: 1
- Feb 5, 2026, Wave Life Sciences, Inc.: 38,750 shares granted. 1 filing: 1
- Jan 2, 2026, Wave Life Sciences, Inc.: sold 9,375 shares for $150K, under a disclosed plan; 9,375 shares acquired by exercising options. 1 filing: 1
- Dec 8, 2025, Wave Life Sciences, Inc.: sold 441,031 shares for $6.4M, under a disclosed plan; 368,531 shares vested or acquired by exercising options; 72,500 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.